Brief: Mainz Biomed Reports Topline Results From Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project
08/10/2025 14:15
Oct 8 (Reuters) - Mainz Biomed NV 4TO.F: MAINZ BIOMED REPORTS TOPLINE RESULTS FROM FEASIBILITY STUDY OF BIOMARKER PANEL IN PANCREATIC CANCER PROJECT Source text: ID:nGNX769C35 Further company coverage: 4TO.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing